Impact of myocardial viability assessed by delayed enhancement cardiovascular magnetic resonance on clinical outcomes in real world practice

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Nor Hanim Mohd Amin

Hospital Raja Permaisuri Bainun Ipoh, Ipoh (Malaysia)

9 More presentations in this session

Presentation thumbnail

Discrimination of fibrotic myocardium from healthy myocardium patients with aortic stenosis: a radiomics approach with machine learning models

Miss K. Siegersma (Amsterdam, NL)

Presentation thumbnail

Midwall late gadolinium enhancement in both nonischemic cardiomyopathy and ischemic heart disease

Ms M. Becker (Amsterdam, NL)

Presentation thumbnail

MRI characteristics and clinical value of hypertrophic cardiomyopathy with scar-like late enhancement

Ms L. Li (Beijing, CN)

Abstract Slides

Presentation thumbnail

New occurrences of macroscopic myocardial fibrosis in thalassemia at long term by multiple follow-up

Doctor A. Meloni (Pisa, IT)

Abstract Slides

Presentation thumbnail

Presence of late gadolinium enhancement and left atrial ejection fraction as predictors of stroke and thrombembolism in patients with hypertrophic cardiomyopathy - a cardiovascular MRI study -

Doctor A. Hohneck (Mannheim, DE)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 5 - Late gadolinium enhancement and viability

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Late gadolinium enhancement and viability

Congress Presentation

CMR in acute coronary syndrome: optional or essential? - discussion

Congress Presentation

Magnetic resonance imaging is the way to go for risk assessment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources